2012-15713. Agreements and Memoranda of Understanding Between the Food and Drug Administration and Other Departments, Agencies, and Organizations; Withdrawal  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Direct final rule; withdrawal.

    SUMMARY:

    The Food and Drug Administration (FDA) published in the Federal Register of March 23, 2012 (77 FR 16923), a direct final rule making technical changes to update a requirement that many of its written agreements and memoranda of understanding with other departments, Agencies, and organizations be published in the Federal Register. The comment period closed June 6, 2012. FDA is withdrawing the direct final rule because the Agency received significant adverse comment.

    DATES:

    The direct final rule published at 77 FR 16923, March 23, 2012, is withdrawn, effective June 27, 2012.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Daniel W. Sigelman, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-4706, FAX: 301-847-8616, email: daniel.sigelman@fda.hhs.gov.

    Start Authority

    Authority: Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, the direct final rule published in the Federal Register on March 23, 2012 (77 FR 16923) is withdrawn.

    End Authority Start Signature

    Dated: June 22, 2012.

    Leslie Kux,

    Assistant Commissioner for Policy.

    End Signature End Further Info End Preamble

    [FR Doc. 2012-15713 Filed 6-26-12; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Comments Received:
0 Comments
Effective Date:
6/27/2012
Published:
06/27/2012
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Direct final rule; withdrawal.
Document Number:
2012-15713
Dates:
The direct final rule published at 77 FR 16923, March 23, 2012, is withdrawn, effective June 27, 2012.
Pages:
38173-38173 (1 pages)
Docket Numbers:
Docket No. FDA-2012-N-0205
PDF File:
2012-15713.pdf
CFR: (1)
21 CFR 20